Table 2.
The survival outcome of different studies.
| Ryu [19] | Shin [20] | Chiu [11] | Cho [12] | Fukunaga [22] | Kim [15] | Najmeh [17] | Park [18] | |
|---|---|---|---|---|---|---|---|---|
| 3 YSR (%) (ESD/surgery) | N/A | N/A | 94.6%/89.7% | N/A | N/A | EC: N/A GC: N/A |
N/A | 80.0%/96.3% |
| OS (%) (ESD/surgery) | N/A | N/A | N/A | 89.8%/90.0% | N/A | EC: 100.5 ± 1.3/84.9 ± 2.6 GC: 93.4 ± 3.2/85.8 ± 5.5 (month) |
100%/90.3% (4 years) | N/A |
| 5-year OS (%) (ESD/surgery) | 100%/100% | N/A | N/A | N/A | 97.1%/85.8% | EC: N/A GC: N/A |
N/A | 97.4%/96.1% |
| DFS (%) (ESD/surgery) | N/A | N/A | N/A | N/A | N/A | EC:93.6 ± 2.5/87.6 ± 2.0 GC: 89.7 ± 3.6/90.4 ± 3.5 (month) |
84.6%/82.6% | N/A |
| 5-year DFS (%) (ESD/surgery) | 85%/97% | N/A | N/A | N/A | N/A | EC: N/A GC: N/A |
N/A | N/A |
| 5 YSR (%) (ESD/surgery) | N/A | 92%/93.3% | N/A | N/A | N/A | EC: N/A GC: N/A |
N/A | N/A |
| P value | 5-year DFS: 0.001 | 0.496 | 0.44 | 0.565 | 0.01 | EC:—OS: 0.397, DFS: 0.597 GC: N/A |
N/A | 3-year SR: <0.001, 5-year OSR: 0.280 |
ESD: endoscopic submucosal dissection; YSR: year survival rate; SR: survival rate; OS: overall survival; OSR: overall survival rate; DFS: disease-free survival; EC: expanded criteria; GC: guideline criteria. N/A: not available.